PCN76 - BUDGET IMPACT ANALYSIS OF AFATINIB FOR THE FIRST-LINE TREATMENT OF ADVANCED OR METASTATIC NON–SMALL-CELL LUNG CANCER IN CHINA
Abstract
Authors
Y. Zhang C.H. Samuelsen I. Griebsch Z. Yao
Y. Zhang C.H. Samuelsen I. Griebsch Z. Yao
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now